NEW YORK, May 29 - France's largest cancer research center, the nonprofit Institut Gustave-Roussy, is scaling up to become a gene expression reference center for European hospitals and universities. IGR said it will provide genomics research services for the European scientific community and also serve as an Agilent microarray analysis training center for scientists in Europe.
The IGR and Agilent announced today that the institute will use Agilent's microarray platform and Rosetta's Resolver bioinformatics system to develop cancer diagnostic tools and provide these services.
Vladimir Lazar, who heads IGR's functional genomics group, said that the Resolver software generates the same results in one day that, with classical mathematical tools would take three weeks to generate.